drugset / Trial / NCT00822419

Percutaneous Ketamine Versus Lidocaine for Mid-Sternotomy

NCT00822419 ↗

Phase 4 Unknown 75 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

Since midsternotomy is painful postoepratively, and since ketamine has been shown to be optimal postoeprative analgessic adjuvant, the investigators wish to assess its percutaneous preemptive effect, comparing it to lidocaine effect.

Timeline

Start
2009-02
Primary completion
2009-06
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 5 % —
Subject Ketamine Small molecule 5 g —
Comparator Lidocaine Other / unclassified 5 % Topical
Comparator Lidocaine Other / unclassified 5 g Topical

Indications

No indication recorded.